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siRNAThe nuclear pore complex (NPC) is a macromolecular assembly consisting of approximately 30 different pro-
teins called nucleoporins. Several nucleoporins are O-GlcNAcylated, which is a post-translational modiﬁca-
tion in which the monosaccharide β-N-acetylglucosamine (GlcNAc) is attached to serine or threonine
residues within proteins. However, the biological signiﬁcance of this modiﬁcation on nucleoporins remains
obscure. Here we found that Nup62 and Nup88 protein levels were signiﬁcantly decreased upon knockdown
of O-GlcNAc transferase (OGT), which catalyzes the O-GlcNAcylation of intracellular proteins. Although
Nup88, unlike Nup62, was not recognized by an anti-O-GlcNAc antibody or WGA–HRP, knockdown of
Nup62 caused a reduction in Nup88 protein levels, suggesting that the observed decrease in Nup88 in OGT
knocked-down cells is due to a decrease in Nup62. Furthermore, we found that Nup88 was preferentially as-
sociated with O-GlcNAcylated Nup62 compared with non-O-GlcNAcylated Nup62. These results indicate that
Nup62 protein levels are primarily maintained by O-GlcNAcylation and that Nup88 is quantitatively regulat-
ed through its interaction with O-GlcNAcylated Nup62.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Nuclear pore complexes (NPCs) aremacromolecular assemblies that
span the nuclear envelope. The NPC, which is composed of approxi-
mately 30 different proteins called nucleoporins [1], is asymmetrically
shaped between the nuclear and cytoplasmic side of the nuclear enve-
lope [2]. Nucleoporins not only comprise the scaffold of the NPC but
also play roles in various cellular processes including nuclear transport
[3], cell differentiation [4,5] and the cell cycle [6]. Most nucleoporins are
organized to form distinct subcomplexes, such as the Nup107–Nup160
[7–10], Nup205–Nup188 [11–14], and Nup62–Nup54 subcomplexes
[15–17], which assemble into the NPC. In yeast, Nup62 forms another
subcomplex, the Nsp1p–Nup82p complex (consisting of the yeast
orthologs of Nup62 and Nup88, respectively) [18,19]. Although, the pri-
mary sequences of nucleoporins are not highly conserved between
yeast and mammals, the NPC structure is well conserved.
Nucleoporins are post-translationally modiﬁed, and phosphorylation
is one of the well-studied modiﬁcations of nucleoporins. Indeed, many
nucleoporins includingmembers of theNup107–Nup160 subcomplexes,O-GlcNAc transferase; OGA,
osciences, Graduate School of
, Suita, Osaka 565-0871, Japan.
l rights reserved.Nup98, gp210, and NDC1 are phosphorylated during mitosis [6,20–23],
and then nuclear envelope breakdown (open mitosis) occurs in higher
eukaryotes. Nucleoporins are also modiﬁed by O-GlcNAcylation [24],
but the biological signiﬁcance of this nucleoporin modiﬁcation remains
unknown.
O-GlcNAcylation is a post-translational modiﬁcation in which
β-N-acetylglucosamine (GlcNAc) is added to serine or threonine resi-
dues within intracellular proteins by O-GlcNAc transferase (OGT)
[25–27]. O-GlcNAcylation is a temporal modiﬁcation, and O-GlcNAcase
(OGA) catalyzes the removal of O-GlcNAc fromproteins [28,29]. Numer-
ous proteins, such as nucleoporins, RNA polymerase II and transcription
factors, are O-GlcNAcylated by OGT and many of the modiﬁed proteins
constitute complexes. Although the exact role of O-GlcNAcylation on
nucleoporins remains to be elucidated, its roles in cell proliferation, tran-
scriptional regulation, protein subcellular localization, and cell signaling
arewell established [30]. For example, O-GlcNAcylation of Stat5a, a tran-
scription factor, has been proposed to enhance transcription of Stat5a-
dependent genes by promoting the association of Stat5a with the tran-
scriptional co-activator [31,32].
In this work, we focus on the O-GlcNAcylation of nucleoporins. We
reveal that down-regulation of O-GlcNAcylation activity leads to a de-
crease in the protein levels of Nup62 and Nup88, but not Nup153, TPR
or Nup96. Furthermore, our results also indicate that Nup88 is quan-
titatively regulated through its interaction with the O-GlcNAcylated
form of Nup62.
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2.1. Cell culture and transfection
HeLa cells were cultured in Dulbecco's modiﬁed MEM (Sigma-
Aldrich) containing 10% fetal bovine serum at 37 °C under 10% CO2.
Cells were transfected using Effectene (Qiagen) according to
manufacturer's instruction.
2.2. siRNA
siRNA duplexes were purchased from NIPPON EGT, including OGT
siRNA1 (5′-GAAGGGCAGUGUUGCUGAA-3′), OGT siRNA2 (5′-GGAUG
GAAUUCAUAUCCUU-3′), Nup62 siRNA1 (5′-AAGCUCAACUUGAGCA
ACA-3′), Nup62 siRNA2 (5′-GCUUCCGGAUCACCUUUGA-3′), Nup88
siRNA1 (5′-AGAGGAGGGUGAACAUAUA-3′), and Nup88 siRNA2 (5′-
GGAUGACCCUUUUGAUUCU-3′). HeLa cells were transfected using
Lipofectamine RNAiMAX (Invitrogen) according to manufacturer's
instructions.OGT
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Fig. 1. Depletion of endogenous OGT causes loss of O-GlcNAc at the nuclear rim. HeLa cells w
Nup153, and actin were detected by RT-PCR. (B) Western blot analysis of whole cell lysates
iﬁcation of proteins was detected by Alexa 594-WGA staining. The binding of WGA to the n
transfected with EGFP-murine OGT expression vector for 48 h.WGA staining was rescued by
or an anti-O-GlcNAc antibody. Whole cell lysates of control or OGT siRNA-treated HeLa cells
or the anti-O-GlcNAc antibody.2.3. Plasmid
To generate pEGFP-murine O-GlcNAc transferase (OGT), the gene
was ampliﬁed by PCR from NIH3T3 cells cDNA which was then
inserted into pEGFP-C1 vector (Clontech). The constructed plasmid
is resistant to human OGT siRNA, which was used for this study.
2.4. Antibodies
Anti-O-GlcNAc transferase (H-300, sc-32921), anti-actin (C-11,
sc-1615), and anti-Lamin B (M-20, sc-6217) antibodieswere purchased
from Santa Cruz Biotechnology. Anti-nucleoporin p62 (610497), anti-
Nup88 (611896), anti-Ran (610340), and anti-karyopherin α2
(610486) antibodies were purchased from BD Biosciences. MAb414
(MMS-120P) and anti-O-GlcNAc (MMS-248R) antibodies were pur-
chased from Covance. Anti-Nup153-IHC (IHC-00366) and anti-TPR
(A300) antibodies were purchased from Bethyl Laboratories. Anti-
Nup96 antibody was described previously (Mizuguchi et al., 2010).
WGA–HRP (J420) was purchased from J-OIL MILLS.*
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was performed to detect the expression of the indicated proteins. (C) O-GlcNAc mod-
uclear rim was reduced by OGT siRNA. (D) After OGT siRNA treatment, HeLa cells were
murine OGT expression. (E) O-GlcNAcylated nucleoporins were detected byWGA–HRP
were immunoprecipitated using a MAb414 antibody and then probed with WGA–HRP
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Total RNA was extracted from control or OGT siRNA-treated HeLa
cells using TRIzol Reagent (Invitrogen) following the manufacturer's
protocol. RT-PCR was performed using the following forward and re-
verse primers that bind to exons: OGT forward (5′-GCGTTTTC
CAGCAGTAGGAG-3′) and reverse (5′-GAGCCGCTCTAGTTCCATTG-3′),
Nup62 forward (5′-GGCTTCACTTTTGGAACAGC-3′) and reverse (5′-
TGGAGCAGTTGCTATTGACG-3′), Nup153 forward (5′-GCTGTCACCCC
ATTTGTCTT-3′) and reverse (5′-TTGTAGTGCTGCTGCCAAAC-3′), actin
forward (5′-AGATCTGGCACCACACCTTC-3′) and reverse (5′-GCCATC
TCGTTCTCGAAGTC-3′), and Nup88 forward (5′-TTCAGAAGCCGAA
GAGGAAA-3′) and reverse (5′-CAGATGCCAGTTTCAAAGCA-3′).
2.6. Indirect immunoﬂuorescence
Control or OGT siRNA-treated HeLa cells were grown on coverslips
and ﬁxed with 3.7% formaldehyde in PBS (137 mM NaCl, 2.7 mM KCl,
3.2 mM Na2HPO412H2O, and 1.5 mM KH2PO4) for 10 min. After
permeabilizing with 0.5% Triton X-100 in PBS for 5 min at room tem-
perature, the cells were washed with PBS and incubated with a
blocking solution (PBS containing 2% BSA). Then, the samples were
incubated with the indicated primary antibodies for 2 h at room tem-
perature. The cells were washed with PBS and incubated with sec-
ondary antibodies for 30 min at room temperature. The cells wereNup62
Control siRNA OGT siRNA1 OGT siRNA2
Nup153
Nup88
TPR
A
Nup96
Fig. 2. The effect of OGT knockdown on nucleoporins protein levels.HeLa cells were transfe
were co-stained with the indicated nucleoporins and Lamin B antibodies. The intensity of Nu
tiﬁcation of the ﬂuorescence intensity of nucleoporins. The graph shows the relative ﬂuores
are shown as 100%). (C) Control or OGT siRNA-treated HeLa cells were stained with the indwashed with PBS four times and the second wash was incubated
with Alexa 594-WGA (Invitrogen) in PBS. Coverslips were mounted
with Vectashield (Vector Laboratories).
2.7. Western blotting
Whole cell lysates of control or OGT siRNA-treated HeLa cells were
prepared using 1% CHAPS in PBS containing protease inhibitors (1 μg/ml
each of leupeptin, pepstatin, and aprotinin). The samples were sepa-
rated by SDS-PAGE and then electrophoretically transferred to mem-
branes. The membranes were blocked with 2% BSA in TBS (20 mM
Tris-HCl pH 7.5 and 150 mM NaCl) (for the anti-O-GlcNAc antibody or
WGA–HRP) or 3% skim milk in TBS (for all other antibodies), and then
incubated with the indicated primary antibodies or WGA–HRP. Next,
the membranes were washed in 0.05% Tween-TBS and incubated with
secondary antibodies for 30 min at room temperature. The membranes
were washed with Tween-TBS. Pierce Western Blotting Substrate
(Thermo Scientiﬁc) was used for detection.
2.8. Immunoprecipitation
Whole cell lysates of control or OGT siRNA-treated HeLa cells were
prepared in 1% CHAPS in PBS containing protease inhibitors (1 μg/ml
each of leupeptin, pepstatin, and aprotinin). The lysates were
preincubated with protein G-sepharose (GE Healthcare) with anti-B
cted with control or OGT siRNA for 72 h. (A) Control or OGT siRNA-treated HeLa cells
p62 and Nup88 at the nuclear rim was reduced upon OGT siRNA knockdown. (B) Quan-
cence intensity of nucleoporins co-localizing with Lamin B. (Control siRNA-treated cells
icated antibodies.
C Control siRNA OGT siRNA1               OGT siRNA2
Control siRNA OGT siRNA1 OGT siRNA2
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Fig. 2 (continued).
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Fig. 3. Nup88 protein levels are down-regulated upon OGT siRNA treatment. HeLa cells
were transfected with control or OGT siRNA for 72 h. (A) Nup88 protein levels in
whole cell lysates were analyzed with speciﬁc antibodies. OGT siRNA causes a reduc-
tion in Nup88. (B) The Nup88 mRNA levels in OGT siRNA knocked-down cells were
detected by RT-PCR. The knockdown did not affect Nup88 mRNA levels.
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Fig. 4. Nup88 is not recognized by either an anti-O-GlcNAc antibody or WGA–HRP.
HeLa cell lysates were immunoprecipitated with an anti-Nup88 antibody or MAb414
and then analyzed by Western blotting. (A) Nup62 and Nup88 were efﬁciently
immunoprecipitated with both anti-Nup88 and MAb414 antibodies. (B) The bands at
the position corresponding to Nup62, but not Nup88, were detected by either an
anti-O-GlcNAc antibody or WGA–HRP. * non-speciﬁc bands, ** heavy chain.
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was incubated with protein G-sepharose and anti-Nup88 or MAb414
antibody for 2 h.
2.9. Confocal microscopy
All imaging analyses were performed using an LSM 510 microscope
(Carl Zeiss). The ﬂuorescence intensity of endogenous nucleoporins
that co-localized with Lamin B was calculated using the image analysis
software associated with the LSM 510 microscope.
3. Results
3.1. OGT mediates the O-GlcNAcylation of nucleoporins
To conﬁrm that O-GlcNAcylation of nucleoporins is mediated by
OGT, we performed siRNA-mediated knockdown of OGT in HeLa cells.
The knockdown efﬁciency was assessed after 72 h and both of the
OGT-speciﬁc siRNAs successfully suppressed OGT mRNA expression
(Fig. 1A). In addition, Western blot analysis showed that the OGT pro-
tein levels were also efﬁciently reduced by OGT-speciﬁc siRNA treat-
ment (Fig. 1B). Furthermore, OGT knockdown decreased overall
O-GlcNAcylation in HeLa cells (Supplemental Fig. 1). Under these
assay conditions, we ﬁrst examined the O-GlcNAc amount of nuclear
rim proteins in OGT siRNA-treated HeLa cells using Alexa 594-WGA,
which speciﬁcally binds to O-GlcNAc. As shown in Fig. 1C, control
siRNA-treated HeLa cells showed marked Alexa 594-WGA staining at
the cell surface, intracellular compartment, and nuclear rim. In contrast,
the signals at the nuclear rimwere clearly decreased inOGT knockdown
cells, although Lamin B staining did not notably changeuponOGT siRNA
treatment. To conﬁrm the speciﬁcity of OGT siRNA, rescue transfection
experiments were performed using an EGFP-murine OGT expressionvector, which is resistant to OGT siRNA because murine OGT does not
contain the OGT siRNA sequence used in these experiments. As shown
in Fig. 1D, the Alexa 594-WGA signals at the nuclear rim of murine
OGT-transfected cells were efﬁciently recovered. These results indicate
that the OGT siRNAs efﬁciently and speciﬁcally suppress OGT expres-
sion, resulting in the inhibition of O-GlcNAcylation of nuclear rim
proteins.
As described above, consistent with previous data [33], OGT knock-
down resulted in a signiﬁcant loss of the Alexa 594-WGA signals at the
nuclear rim, indicating that the level of O-GlcNAcmodiﬁcation of nuclear
rim proteins is decreased upon OGT knockdown. Therefore, to conﬁrm
2686 C. Mizuguchi-Hata et al. / Biochimica et Biophysica Acta 1833 (2013) 2682–2689that nucleoporins are O-GlcNAcylated by OGT, we examined whether
the O-GlcNAc modiﬁcation levels of Nup62 and Nup153, which are
known to be O-GlcNAcylated, are decreased in OGT knockdown cells.
To conﬁrm that, we immunoprecipitated Nup62 and Nup153 and then
probed with WGA–HRP or the anti-O-GlcNAc antibody. As shown in
Fig. 1E, WGA and the anti-O-GlcNAc antibody reactivities against
Nup62 and Nup153 decreased signiﬁcantly in OGT knockdown cells.
These results indicate that OGT mediates O-GlcNAcylation of these nu-
clear pore complex proteins.3.2. OGT knockdown down-regulates Nup62 and Nup88 protein levels
Furthermore, we noticed that Nup62 protein levels, but not mRNA
levels, were down-regulated in OGT knockdown cells (Fig. 1A & B).
Therefore, to further elucidate the effects of OGT knockdown on the
protein levels of individual nucleoporins, we examined the expression
of several nucleoporins in OGT knockdown cells. Immunoﬂuorescence
stainingwas performed onOGT siRNA-treatedHeLa cells using antibod-
ies speciﬁc for several nucleoporins (Nup62, Nup88, Nup153, TPR, and
Nup96). To quantify the amount of nucleoporins located only at the
nuclear rim, we co-stained nucleoporins and Lamin B and calculated
the relative amount of nucleoporins that co-localized with Lamin B.
As shown in Fig. 2, OGT knockdown did not notably affect the levels
of Nup153, TPR, and Nup96, although Nup153 was noticeably
O-GlcNAcylated (Fig. 1E). In addition, the cellular localization of both
Ran and importin α did not change upon OGT siRNA knockdown
(Fig. 2C). In contrast, in OGT knockdown cells, the Nup62 and Nup88Co
nt
ro
l s
iR
NA
 
N
up
62
 s
iR
NA
1
N
up
62
 s
iR
NA
2
Nup88Nup62A
Fig. 5. Nup62 and Nup88 mutually affect protein levels.HeLa cells were transfected with the
ting analyses were performed. Quantiﬁcation of the ﬂuorescence intensity of Nup88 or Nup6
intensity of Nup88 or Nup62 co-localizing with Lamin B. (Control siRNA-treated cells are sho
down decreased Nup62 protein levels.signals at the nuclear rim and Nup88 cytoplasmic signals were clearly
reduced. Furthermore, as shown in Fig. 3, we found that Nup88 protein
levels, but not mRNA levels, were also signiﬁcantly reduced upon OGT
knockdown. These results raise the possibility that OGT, and likely
O-GlcNAcylation, affects the protein levels of certain nucleoporins.
3.3. Nup88 is not evidently O-GlcNAcylated, unlike Nup62
Whereas Nup62 is well known to be O-GlcNAcylated, it is not
known whether Nup88 is O-GlcNAcylated. In order to determine
whether the observed reduction in Nup88 protein levels in OGT
knockdown cells is due to the lack of O-GlcNAcylation of Nup88, we
examined whether Nup88 is O-GlcNAcylated. To conﬁrm this ﬁnding,
we performed immunoprecipitation analysis using a Nup88-speciﬁc
antibody followed by Western blot analysis with an anti-O-GlcNAc
antibody and WGA–HRP. In addition, we also immunoprecipitated
O-GlcNAcylated Nup62 using MAb414 as a control. As shown in
Fig. 4, although the anti-Nup88 antibody and MAb414 efﬁciently
immunoprecipitated Nup88, the band corresponding to Nup88 was
not recognized by either the anti-O-GlcNAc antibody or WGA–HRP.
O-GlcNAcylation of Nup88, unlike Nup62, is inconclusive in our ex-
perimental condition.
3.4. Nup62 and Nup88 mutually affect their protein levels
We also noticed that a signiﬁcant amount of Nup62 co-
immunoprecipitated with Nup88 (Fig. 4), suggesting that Nup88,Nup88
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Fig. 5 (continued).
2687C. Mizuguchi-Hata et al. / Biochimica et Biophysica Acta 1833 (2013) 2682–2689directly or indirectly, interacts with Nup62. Consistent with this ﬁnd-
ing, it is known that Nup82p, the yeast ortholog of Nup88, forms a
subcomplex with Nsp1p [18], the yeast ortholog of Nup62. These re-
sults raise the possibility that the interaction between Nup88 and
Nup62 affects Nup88 protein levels. To examine this possibility, we
investigated whether Nup62 knockdown affects Nup88 protein levels
in HeLa cells. As shown in Fig. 5A, Nup62 knockdown dramatically re-
duced Nup88 immunoﬂuorescence signals at the nuclear rim and in
the cytoplasm. In addition, the Nup88 protein levels in whole cell
lysates were reduced upon Nup62 knockdown (Fig. 5A). Furthermore,Nu
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Fig. 6. O-GlcNAcylation-dependent association between Nup88 and Nup62. Control or OGT
antibody and subsequently analyzed byWestern blotting. Because the Nup88 protein levels w
of Nup88 protein was immunoprecipitated.we found that siRNA-mediated knockdown of Nup88 also caused a
reduction in Nup62 signals at the nuclear rim (Fig. 5B). These results
suggest that Nup62 and Nup88 mutually affect their protein levels.
Furthermore, because the Nup88–Nup214 interaction is well
established [34], we examined whether Nup214 knockdown affects
Nup62 protein levels. As shown in Supplemental Fig. 2A, Nup214
siRNA knockdown caused a reduction in Nup62 protein levels. In ad-
dition, the Nup214 protein levels were reduced with the knockdown
of Nup62 (Supplemental Fig. 2B). These results suggest that Nup214
is also associated with the Nup88–Nup62 subcomplex.p88
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Finally, we analyzed whether the interaction between Nup62 and
Nup88 is regulated by O-GlcNAcylation of Nup62. Cell lysates from con-
trol or OGT siRNA-treated HeLa cells were immunoprecipitated with an
anti-Nup88 antibody. As shown in Fig. 6, the amount of Nup62 that
co-immunoprecipitated with Nup88 was signiﬁcantly decreased upon
treatment with either of the two OGT siRNAs, indicating that Nup88
preferentially associates with O-GlcNAcylated Nup62 in vivo.
These ﬁndings indicate that the interaction between Nup62 and
Nup88 is controlled by O-GlcNAcylation of Nup62.
4. Discussion
Although O-GlcNAcylation is an established post-translational
modiﬁcation of nuclear envelope proteins including nucleoporins,
its biological signiﬁcance has remained largely unknown. In this
work, we demonstrated that OGT knockdown reduced Nup62 and
Nup88 protein levels. Our results showed that Alexa 594-WGA stain-
ing at the nuclear rim was signiﬁcantly reduced upon OGT knock-
down (Fig. 1C), which is consistent with a previous report [33], and
Nup62 and Nup153 recognition by WGA–HRP or the anti-O-GlcNAc
antibody were signiﬁcantly decreased upon OGT knockdown
(Fig. 1E). In addition, we noticed that murine OGT-transfected control
and OGT siRNA-treated cells showed enhanced nuclear rim staining
by Alexa 594-WGA, compared to non-transfected cells (Fig. 1D).
These results suggest that OGT activity should be controlled to main-
tain the O-GlcNAcylation levels of nucleoporins at the appropriate
level.
Nup62 is amajor glycoprotein [24] that constitutes twonucleoporins
subcomplexes. One is the complexwith Nup54 andNup58 that localizes
at the central plague of theNPC [16], while the other complex consists of
Nup82p (yeast ortholog of Nup88) and Nup159p (yeast ortholog of
Nup214), which have been reported in yeast [19]. Our study showed
that an anti-O-GlcNAc antibody and WGA–HRP did not recognize
Nup88 and that Nup62 knockdown resulted in a reduction in Nup88.
These results suggest that the reduction inNup88 uponOGT knockdown
is caused by a decrease in Nup62 and that Nup88 may be stabilized
through its interaction with Nup62. Interestingly, Nup88 siRNA knock-
down also diminished the staining of Nup62 at the nuclear rim. There-
fore, it is likely that these two nucleoporins are stabilized through
complex formation. Furthermore, our results show that Nup88 prefer-
entially binds to O-GlcNAcylated Nup62, compared with the non-O-
GlcNAcylated form, suggesting that O-GlcNAcylation enhances the in-
teraction between Nup88 and Nup62.
The homologue of OGT has not been reported in yeast.We speculate
that theremay be different regulatorymechanisms betweenNup62 and
Nup88 interaction in higher eukaryotes and yeast. In higher eukaryotes,
nuclear envelope breaks downduringmitosiswith a concomitant disas-
sembly of NPC into nucleoporins subcomplexes [6]. Furthermore, these
NPCs have to be efﬁciently reassembled during exiting frommitosis. On
the other hand, both Nup82p and Nsp1p continue to localize at NPC
throughout the cell cycle in yeast [35]. Thus, O-GlcNAcylation of
nucleoporins may contribute to the temporal regulation of disassembly
and reassembly of nucleoporins in higher eukaryotes. In addition, in
higher eukaryotes,manynucleoporins are phosphorylated duringmito-
sis. Phosphorylation has been shown to be important for the NPC disas-
sembly [21]. Therefore, competitive modiﬁcation of O-GlcNAcylation
with phosphorylation may play a role in the regulation of NPC disas-
sembly and reassembly.
Nup88 has also been shown to be involved in the regulation of the
nucleocytoplasmic trafﬁcking of molecules. In Drosophila mbo
(DNup88 mutants), the efﬁciency of EGFP-NES export is increased
[36]. In contrast, in mammalian cells, the Nup88–Nup214 subcomplex
is required for CRM1-dependent nuclear protein export. Indeed, some
nuclear proteins could not be exported from the nucleus efﬁcientlywhen the Nup88–Nup214 complex was depleted [37,38]. Further-
more, Nup82p plays an essential role in RNA export in yeast [39].
Therefore, Nup88 most likely plays a role in the nucleocytoplasmic
transport of molecules. Accordingly, in OGT siRNA-treated cells, the
export of protein/RNA may be disrupted because Nup88 is reduced
at the nuclear rim. These points should be addressed in future studies.
Nup88 is overexpressed in various tumor cells [40–42]. Interest-
ingly, immunoblot analysis showed that Nup88 is overexpressed in
several lung carcinomas, although the Nup153 and Nup214 protein
levels are similar to control cells [43]. Furthermore, breast, lung and
colon cancer cells have higher OGT expression than normal cells,
and in particular, poorly differentiated tumors have signiﬁcantly
higher OGT expression [44,45]. Therefore, it will be interesting to elu-
cidate the relationship between OGT and Nup88 overexpression in
carcinogenesis.
In summary, our results show that OGT-mediated O-GlcNAcylation
regulates the interaction between Nup62 and Nup88, and that affects
Nup62 and Nup88 protein expression.
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